| Cash Flow | 2025-09-30 |
|---|---|
| Net income/(loss) | 122,464 |
| Net (gain)/loss on residential whole loans | 133,033 |
| Impairment and other net (gain)/loss on securities and other portfolio investments, net | -45,828 |
| Net (gain)/loss on real estate owned | -4,210 |
| Accretion of purchase discounts and amortization of purchase premiums on residential whole loans and securities | 682 |
| Provision/(reversal of provision) for credit losses on residential whole loans and other assets | 1,212 |
| Net (gain)/loss on derivatives used for risk management purposes | -66,214 |
| Net (gain)/loss on securitized debt measured at fair value through earnings | -43,589 |
| Net margin received/(paid) for derivatives used for risk management purposes | 96,176 |
| Net other non-cash (gains)/losses included in net income | 59,688 |
| (increase)/decrease in other assets | -9,164 |
| Increase/(decrease) in other liabilities | 7,797 |
| Net cash provided by/(used in) operating activities | 38,619 |
| Purchases and origination of residential whole loans, loan related investments and capitalized advances | 2,030,362 |
| Proceeds from sales of residential whole loans | 220,293 |
| Principal payments on residential whole loans and loan related investments | 1,845,793 |
| Purchases of securities | 817,636 |
| Proceeds from sales of securities and other assets | 20,790 |
| Principal payments on securities | 171,918 |
| Proceeds from sales of real estate owned | 73,957 |
| Other investing activities | 38,779 |
| Net cash provided by/(used in) investing activities | -554,026 |
| Principal payments on financing agreements with mark-to-market collateral provisions | 2,014,431 |
| Proceeds from borrowings under financing agreements with mark-to-market collateral provisions | 2,477,850 |
| Principal payments on other collateralized financing agreements | 1,293,259 |
| Proceeds from borrowings under other collateralized financing agreements | 1,461,303 |
| Payments made for other collateralized financing agreement related costs | 8,039 |
| Redemption and repurchase of convertible senior notes | 0 |
| Proceeds from issuance of senior notes | 0 |
| Payments made for settlements and unwinds of swaps | 26,020 |
| Proceeds from issuance of preferred stock | 4,532 |
| Payments made for costs related to preferred stock issuance | 74 |
| Proceeds from issuances of common stock, net of expenses | -61 |
| Payments made for the repurchase of common stock | 10,266 |
| Dividends paid on preferred stock | 29,613 |
| Dividends paid on common stock and dividend equivalents | 110,858 |
| Net cash provided by/(used in) financing activities | 451,064 |
| Net increase/(decrease) in cash, cash equivalents and restricted cash | -64,343 |
| Cash and cash equivalents at beginning of period | 601,312 |
| Cash and cash equivalents at end of period | 536,969 |
MFA FINANCIAL, INC. (MFAN)
MFA FINANCIAL, INC. (MFAN)